Related Experiment Video
Updated: Jul 7, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex
Lin Huang1, Miki Shitashige, Reiko Satow
1Chemotherapy Division and Cancer Proteomics Project, National Cancer Center Research Institute, Tokyo, Japan.
Background & Aims:
The Wnt signaling pathway is activated constitutively in the majority of colorectal cancers as a result of mutation in either the adenomatous polyposis coli or the CTNNB1 gene, and blockage of the pathway has been considered feasible as molecular therapy against colorectal cancer. DNA topoisomerase IIalpha (Topo IIalpha) is a component of the beta-catenin/T-cell factor-4 (TCF-4) nuclear complex. We examined the functional significance of Topo IIalpha in Wnt signaling.
Methods:
The physical and functional interaction between Topo IIalpha and the beta-catenin/TCF-4 nuclear complex was evaluated by immunoprecipitation, immunofluorescence microscopy, 2-hybrid assay, and luciferase reporter assay.
Results:
Amino acids 951-1301 of Topo IIalpha were necessary for binding to beta-catenin. Over expression of Topo IIalpha enhanced the TCF/lymphoid enhancer factor transcriptional activity in a dose-dependent manner, and knockdown of Topo IIalpha by RNA interference conversely attenuated the transcriptional activity. The Topo II inhibitors, merbarone and etoposide, suppressed the beta-catenin-mediated TCF/lymphoid enhancer factor transcriptional activity. The catalytic activity of Topo II was augmented by overexpression of beta-catenin as measured by the decatenation of kinetoplast DNA. Topo IIalpha was highly expressed and colocalized with beta-catenin in tumor cells of patients with familial adenomatous polyposis syndrome and patients with sporadic colorectal cancer.
Conclusions:
Topo IIalpha interacts with beta-catenin as a novel transcriptional co-activator. A new drug targeting the interaction of Topo IIalpha with beta-catenin as well as its catalytic activity might be more effective for suppressing aberrant Wnt signaling and proliferation of colorectal cancer cells than the current Topo II inhibitors.
Insights
DNA topoisomerase IIalpha (Topo IIalpha) acts as a co-activator in colorectal cancer by interacting with beta-catenin. Targeting this interaction may offer a more effective therapy for colorectal cancer than current Topo II inhibitors.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- The Wnt signaling pathway is frequently activated in colorectal cancer due to mutations in adenomatous polyposis coli or CTNNB1.
- DNA topoisomerase IIalpha (Topo IIalpha) is a component of the beta-catenin/T-cell factor-4 (TCF-4) nuclear complex, suggesting a role in Wnt signaling.
Purpose of the Study:
- To investigate the functional significance of Topo IIalpha in Wnt signaling within the context of colorectal cancer.
- To determine the interaction between Topo IIalpha and the beta-catenin/TCF-4 complex.
Main Methods:
- Evaluated the physical and functional interaction using immunoprecipitation, immunofluorescence microscopy, 2-hybrid assay, and luciferase reporter assay.
- Assessed Topo IIalpha's catalytic activity via kinetoplast DNA decatenation.
- Examined Topo IIalpha expression in patient tumor samples.
Main Results:
- Topo IIalpha binds to beta-catenin via amino acids 951-1301.
- Overexpression of Topo IIalpha enhanced TCF/lymphoid enhancer factor transcriptional activity, while knockdown attenuated it.
- Topo II inhibitors suppressed beta-catenin-mediated transcriptional activity, and Topo II catalytic activity was augmented by beta-catenin overexpression.
- High expression and co-localization of Topo IIalpha and beta-catenin were observed in colorectal tumors.
Conclusions:
- Topo IIalpha functions as a novel transcriptional co-activator by interacting with beta-catenin.
- Targeting the Topo IIalpha-beta-catenin interaction and Topo IIalpha's catalytic activity could be a superior therapeutic strategy for colorectal cancer.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
DNA Damage can Stall the Cell Cycle
General Transcription Factors
DNA Damage Can Stall the Cell Cycle
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin homology) domains...

